Dr. Maryum H. Merchant, MD

Dr. Merchant practices at Thousand Oaks Pain Management Clinic in Thousand Oaks, California.

Dr. Merchant's NPI, 1902024532, was assigned on April 20, 2007. Dr. Merchant graduated from Dow University of Health Sciences in 2002. Dr. Merchant holds California license A96675.

Dr. Merchant's primary practice is Thousand Oaks Pain Management Clinic, at 100 Moody Court, Suite #100, Thousand Oaks, CA 91360. The practice phone is (805) 418-3444.

Dr. Merchant's primary practice is Thousand Oaks Pain Management Clinic in Thousand Oaks, California. Dr. Merchant is also affiliated with Los Robles Regional Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Merchant to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Merchant practices, 6 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Merchant's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Merchant is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Merchant is licensed in California.

Dmand AI lists acute sinusitis, asthma, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, chronic sinusitis, pleural effusion and pneumonia among the conditions Dr. Merchant treats.

CMS data shows 3,043 Medicare services from Dr. Merchant across 18 procedure codes in 2024, for 830 Medicare patients. Medicare paid $231,026 for them.

CMS counts 830 Medicare patients who saw Dr. Merchant in 2024. The largest group is 75 to 84, with 340 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Merchant's median patient age at 70, with 58% women.

In 2024, Dr. Merchant wrote 3,313 Medicare Part D claims for 587 patients. CMS names the drug for 3,075 of them, across 42 drugs with 11 or more claims each, at $1,774,770 in total drug cost. In 2023, CMS named 3,190 claims across 46 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Merchant for performance year 2024, reported as part of a group. Dr. Merchant accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Merchant as offering telehealth.

Dmand AI links 3 papers to Dr. Merchant, published from 2007 to 2024. Dr. Merchant's most frequent co-authors are Michael I. Lewis, MD and Robert D. Libke, MD.

CMS Open Payments shows 30 general payments to Dr. Merchant from 13 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 69% of the total. Sanofi and Genzyme US Companies paid the most, $2,642.

Dr. Merchant graduated from Dow University of Health Sciences in 2002.

Dr. Merchant is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.